|
Inferring PDL-1 status from H&E images using digital pathology to identify patients responsive to anti-PD(L)-1 immuno-oncology therapy for bladder cancer trials. |
| |
|
Employment - Johnson & Johnson/Janssen |
Stock and Other Ownership Interests - Johnson & Johnson/Janssen |
Patents, Royalties, Other Intellectual Property - Johnson & Johnson/Janssen |
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen |
| |
|
Employment - Johnson & Johnson/Janssen |
Research Funding - Johnson & Johnson/Janssen (Inst) |
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen |
| |
|
Employment - Johnson & Johnson/Janssen |
Stock and Other Ownership Interests - Johnson & Johnson/Janssen |
| |
|
Employment - AstraZeneca (I); Johnson & Johnson/Janssen |
Stock and Other Ownership Interests - JJ Innovative Medicine |
Patents, Royalties, Other Intellectual Property - Johnson & Johnson/Janssen |
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen |
| |
|
Employment - Johnson & Johnson/Janssen |
Stock and Other Ownership Interests - JJ Innovative Medicine |
Patents, Royalties, Other Intellectual Property - AI Therapeutics |
Travel, Accommodations, Expenses - JJ Innovative Medicine |
| |
|
Employment - Janssen Research & Development |
Leadership - Janssen Research & Development |
Stock and Other Ownership Interests - Janssen Research & Development |
Research Funding - Janssen Oncology |
Patents, Royalties, Other Intellectual Property - 4 patents (Inst) |
Travel, Accommodations, Expenses - Janssen Research & Development |
| |
|
Employment - JJ Innovative Medicine |
Stock and Other Ownership Interests - JJ Innovative Medicine |
| |
|
No Relationships to Disclose |
| |
|
Employment - Johnson & Johnson/Janssen; Merck (I) |
Stock and Other Ownership Interests - Johnson & Johnson/Janssen; Merck (I) |
Research Funding - Johnson & Johnson/Janssen |
Patents, Royalties, Other Intellectual Property - Johnson & Johnson/Janssen |
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen; Merck (I) |